The decreased concentration of CSF TCN2 in Parkinson’s disease was probably caused by disturbed lysosomal acidification and protease inhibition [23], except that severe deficiency of VB12 was also linked to cognitive decline [24, 25]. Here, TCN2 is linked to Parkinson disease.